The INPPL1 E567G mutation discovered in tumor CLN2 resides within the catalytic inositol polyphosphate 5-phosphatase domain that is critical to inositol phosphatase activity, and is predicted to be damaging by SIFT. Here, TPP1 is linked to neoplasm.